Building Quinn, an AI scientist accelerating pharma/biotech R&D
Company is active
Event Year: 2022
Company is active
Event Year: 2022
iollo is dedicated to revolutionizing the pharmaceutical and biotechnology research and development landscape with Quinn, an AI-powered scientist. Quinn is designed to automate the complete drug development lifecycle, spanning from initial target discovery to the formulation of comprehensive commercial strategies. By synthesizing vast amounts of scientific, clinical, and market data, Quinn dramatically accelerates complex R&D processes. Tasks that traditionally consume years for pharmaceutical teams can now be accomplished in a matter of hours, significantly enhancing efficiency and accelerating the delivery of life-saving treatments.
iollo is dedicated to revolutionizing the pharmaceutical and biotechnology research and development landscape with Quinn, an AI-powered scientist. Quinn is designed to automate the complete drug development lifecycle, spanning from initial target discovery to the formulation of comprehensive commercial strategies. By synthesizing vast amounts of scientific, clinical, and market data, Quinn dramatically accelerates complex R&D processes. Tasks that traditionally consume years for pharmaceutical teams can now be accomplished in a matter of hours, significantly enhancing efficiency and accelerating the delivery of life-saving treatments.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2022
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2022
Healthcare
Healthcare
Healthcare -> Drug Discovery and Delivery
Healthcare -> Drug Discovery and Delivery
Team size: 4
Hiring: No
Team size: 4
Hiring: No
